Vaxer Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 0.55 M
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.00 Cr
About Vaxer Pharma
Vaxer Pharma Limited (VPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 30 August 2011 and has a history of 13 years and five months. Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.55 M.
The company currently has active open charges totaling ₹15.00 Cr.
Pochiraju Rao, Anshul Sikri, Bodh Sikri, and Two other members serve as directors at the Company.
Company Details
-
Location
Gurugram, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999HR2011PLC122348
-
Company No.
224400
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
30 Aug 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vaxer Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suman Malhotra
|
Director | 27-Mar-2021 | Current |
|
Pochiraju Rao
|
Director | 30-Aug-2011 | Current |
|
Anshul Sikri
|
Director | 30-Aug-2011 | Current |
|
Bodh Sikri
|
Director | 16-Jan-2014 | Current |
|
Aastha Dewan
|
Director | 27-Mar-2021 | Current |
Financial Performance of Vaxer Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaxer Pharma?
Unlock access to Vaxer Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Abs Mercantiles Private LimitedPochiraju Rao and Bodh Sikri are mutual person
-
Berg Healthcare LlpPochiraju Rao and Anshul Sikri are mutual person
-
S B Organics Ltd
Pochiraju Rao, Anshul Sikri and 2 more are mutual person
-
Aumento Pallinos Private Limited
Pochiraju Rao and Bodh Sikri are mutual person
-
Anm Pharma Private Limited
Anshul Sikri is a mutual person
-
Nxis Hospitality Llp
Bodh Sikri is a mutual person
Charges (Loans)
₹15.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2022 | Yes Bank Limited | ₹15.00 Cr | Open |
How Many Employees Work at Vaxer Pharma?
Unlock and access historical data on people associated with Vaxer Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaxer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaxer Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
